Filing Overview
Blue Water Vaccines Inc. filed a Form 8-K on April 20, 2022 under Item 8.01, Other Events. The filing announces the closing of an at-the-market private placement. The request metadata identifies Onconetix, Inc.; however, the filing itself identifies the registrant as Blue Water Vaccines Inc. (Nasdaq: BWV).
Financial and Capital Markets Information
- The filing does not provide the private placement size, number of securities issued, offering price, proceeds, fees, dilution, or use of proceeds.
- No revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics are disclosed.
- The filing does not provide a clear description of the securities sold or the terms of the at-the-market private placement.
Material Changes and Outlook
The material event reported is the closing of the at-the-market private placement. No guidance, forecast, management outlook, risk update, contingency, or unusual operating item is described in the filing text.
Exhibits and Verification Points
- Exhibit 99.1 is a press release dated April 20, 2022 and is incorporated by reference, but its contents are not included in the provided filing text.
- Investors should verify the transaction size, securities issued, pricing, proceeds, dilution, and use of proceeds in Exhibit 99.1 or related filings.
- Investors should confirm the registrant identity because the provided metadata names Onconetix, Inc., while the filing names Blue Water Vaccines Inc.
- Investors should review subsequent filings for the accounting treatment and balance-sheet impact of the financing.